#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15094	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2480	749.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1883	1883	T	977	T,G,C,A	973,2,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15094	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2480	749.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1617	1617	C	972	C	972	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25924	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4062	795.4	0	.	n	.	0	T695C	SNP	695	695	T	1284	1284	C	927	C,A,T,G	918,5,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25924	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4062	795.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2560	2560	C	928	C,T,A	925,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25924	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4062	795.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2634	2634	A	872	A,G	870,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25924	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4062	795.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3186	3186	C	947	C,G,A	942,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2328	folP	855	855	100.0	folP.l15.c30.ctg.1	2045	141.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1254	1256	AGC	217;220;221	A,G;G;C	216,1;220;221	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5298	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3799	173.7	1	SNP	p	S91F	0	.	.	271	273	TCC	807	809	TCC	210;210;210	T,A;C;C	209,1;210;210	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5298	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3799	173.7	1	SNP	p	D95N	0	.	.	283	285	GAC	819	821	GAC	216;218;219	G;A,G;C	216;217,1;219	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5298	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3799	173.7	1	SNP	p	D95G	0	.	.	283	285	GAC	819	821	GAC	216;218;219	G;A,G;C	216;217,1;219	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1958	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1681	145.0	1	SNP	p	G45D	0	.	.	133	135	GGC	707	709	GGC	218;218;217	G,C;G;C	217,1;217;216	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1082	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1551	87.1	0	.	n	.	0	A197.	DEL	197	197	A	883	883	A	215	A	215	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4852	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3409	177.3	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1670	1672	ATC	249;250;251	A;T;C	249;250;251	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4852	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3409	177.3	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1823	1825	GCA	255;257;258	G;C,G;A	254;255,1;257	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4852	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3409	177.3	1	SNP	p	D86N	0	.	.	256	258	GAC	776	778	GAC	205;207;206	G;A;C,G	205;207;205,1	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4852	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3409	177.3	1	SNP	p	S87W	0	.	.	259	261	AGT	779	781	AGT	207;209;209	A,T;G;T	206,1;209;209	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4852	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3409	177.3	1	SNP	p	S87I	0	.	.	259	261	AGT	779	781	AGT	207;209;209	A,T;G;T	206,1;209;209	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4852	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3409	177.3	1	SNP	p	S87R	0	.	.	259	261	AGT	779	781	AGT	207;209;209	A,T;G;T	206,1;209;209	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4852	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3409	177.3	1	SNP	p	S88P	0	.	.	262	264	TCC	782	784	TCC	209;209;213	T;C,G;C	209;208,1;213	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4368	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3168	172.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1762	1764	GGC	255;252;252	G,T;G,T;C,A	254,1;251,1;250,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1562	1564	GCA	225;226;230	G;C,T;A,G,C	225;225,1;228,1,1	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1565	1567	ATC	231;230;229	A,T;T;C	230,1;230;229	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1577	1579	GTG	234;236;236	G;T,C;G	234;235,1;236	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1577	1579	GTG	234;236;236	G;T,C;G	234;235,1;236	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2081	2083	ACC	240;244;244	A;C;C,A	240;244;243,1	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2135	2137	GCG	240;242;240	G,A;C,G;G	239,1;241,1;240	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2135	2137	GCG	240;242;240	G,A;C,G;G	239,1;241,1;240	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2258	2260	GGC	240;238;237	G;G;C	240;238;237	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2267	2269	GGC	249;249;250	G;G,C;C	249;248,1;250	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4232	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2918	180.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2285	2287	CCG	246;246;246	C,G;C;G	243,3;246;246	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5658	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3378	208.4	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1639	1641	ACG	248;248;243	A;C;G,A	248;248;242,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2356	porA	1146	1146	99.39	porA.l15.c4.ctg.1	2302	127.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	595	597	GGC	148;151;150	G,T;G;C	147,1;151;150	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2356	porA	1146	1146	99.39	porA.l15.c4.ctg.1	2302	127.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	777	777	C	191	C	191	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	T26A	NONSYN	76	78	ACC	600	602	GCC	265;267;266	G;C,T;C	265;266,1;266	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	K41D	NONSYN	121	123	AAA	645	647	GAC	281;278;280	G;A,C;C	281;277,1;280	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	951	953	CAA	250;256;256	C,A;A;A,C	249,1;256;255,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	1083	1085	CAA	337;340;343	CAAAA,CAAA;A;A	324,1;340;342	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	N189S	NONSYN	565	567	AAC	1089	1091	AGC	349;346;345	A;G;C,A	349;346;344,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	I209M	NONSYN	625	627	ATC	1149	1151	ATG	338;337;334	A;T,C;G	336;336,1;334	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	.	MULTIPLE	632	633	GC	1157	1160	AGAT	351;353;348;343	A,G;G,C;A;T,C,A	350,1;352,1;348;340,2,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	Q213L	NONSYN	637	639	CAG	1164	1166	TTA	349;350;349	T;T,G;A,T	349;348,2;348,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	S216I	NONSYN	646	648	AGC	1173	1175	ATC	357;357;356	A;T;C,G,A	357;357;354,1,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	R256S	NONSYN	766	768	CGT	1293	1295	AGT	294;295;296	A;G;T	294;295;296	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1404	1406	AGT	277;277;278	A;G,T;T,G,A	277;276,1;276,1,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1410	1412	GAC	275;276;278	G;A;C	275;276;278	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	1	SNP	p	G120K	1	.	.	358	360	AAG	882	884	AAG	262;267;267	A;A;G	262;267;267	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	1	SNP	p	A121D	1	.	.	361	363	GAC	885	887	GAC	267;266;266	G;A,G;C	267;265,1;266	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	3424	porB1b	1041	1041	97.7	porB1b.l6.c4.ctg.1	2033	209.5	1	SNP	p	D121N	0	.	.	361	363	GAC	885	887	GAC	267;266;266	G;A,G;C	267;265,1;266	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10610	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5332	248.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2247	2249	AAT	264;264;264	A;A;T	264;264;264	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1568	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1591	123.0	1	SNP	p	V57M	1	.	.	169	171	ATG	783	785	ATG	280;280;278	A;T,C;G	280;279,1;278	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
